Form 4 · Filed May 8, 2026, 08:28 PM UTC
AMRX/Amneal Pharmaceuticals, Inc.
Autor Deborah M. — Chief Policy Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 7, 2026 | M | other | 34,819 | — | — | 128,479 |
| May 7, 2026 | M | other | 34,819 | — | — | 0 |
| May 6, 2026 | A | other | 19,824 | — | — | 19,824 |
Source: SEC EDGAR raw filing ↗ · Accession 0001628280-26-032925